Aug 14, 2024 / 01:00PM GMT
Operator
Good morning, and welcome to the ImmuCell Corporation Reports second quarter ended June 30, 2024, unaudited financial results conference call. (Operator Instructions)Please note this event is being recorded. I'll now like to turn the conference call over to Joe Diaz of Lytham Partners. Please go ahead.
Joe Diaz - Lytham Partners LLC - Investor Relations
Thank you, Anthony. Good morning and welcome. As Anthony indicated, my name is Joe Diaz with Lytham Partners. We are the Investor Relations consulting firm for ImmuCell. Thank all of you for joining us today to discuss the unaudited financial results for the quarter ended June 30, 2024.
Listeners are reminded and cautions that statements made by management during the course of this call include forward-looking statements, which include any statements that refer to future events, our expected future results or predictions about steps the company plan to take in the future.
These statements are not guarantees of performance and are subject to risks and uncertainties that could cause actual
Q2 2024 ImmuCell Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot